Vogt-Koyanagi-Harada syndrome;Le syndrome de Vogt-Koyanagi-Harada

Revue Neurologique

Volumn 161, Issue 11, 2005, Pages 1079-1090

  Blanc, F ^a,b   Fleury, M ^a   Talmant, V ^a   Deroide, N ^a   Szwarcberg, J ^b   Tranchant, C ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b HÔPITAL CIVIL   (France)

Author keywords

Autoantibodies; Autoimmune Disease; HLA Typing; Uveitis; Uveomeningoencephalitic Syndrome

Indexed keywords

ANTIBODY; ARRESTIN ANTIBODY; CHOROID ANTIBODY; COCHLEA ANTIBODY; CORTICOSTEROID; CYCLOPHOSPHAMIDE; HLA ANTIGEN CLASS 2; RETINA S ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ARTICLE; CASE REPORT; DISEASE COURSE; FACIAL NERVE PARALYSIS; FEMALE; HLA TYPING; HUMAN; LYMPHOCYTE; MALE; MENINGITIS; UVEITIS; VESTIBULAR DISORDER; VOGT KOYANAGI SYNDROME;

EID: 29444431757     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-3787(05)85175-6     Document Type: Article

References (60)

1. ANDRADE RE, MUCCIOLI C, FARAH ME, NUSSENBLATT RB, BELFORT R. (2004). Intravitreal Triamcinolone in the treatment of serous retinal detachment in Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol, 137: 572-574.
2. ARIGA H, OHNO S, HIGUCHI M, MATSUDA H. (1998). Immunological studies on lymphocytes in the cerebrospinal fluid of patients with Vogt-Koyanagi-Harada disease and sympathetic ophthalmia. Nippon Ganka Ogakkai Zasshi, 92: 225-228.
3. BABEL J. (1932). Syndrome de Vogt-Koyanagi-Harada (uvéite bilatérale, poliosis, alopécie, vitiligo et dysacousie). Schweiz Med Wochenschr, 44: 1136-1140.
4. BENIZ J, FORSTER DJ, LEAN JS, SMITH RE, RAO NA. (1991). Variations in clinical features of the Vogt-Koyanagi-Harada syndrome. Retina, 11: 275-280.
5. BORGHESAN E. (1964). Nature of a pigmented substance in the labyrinth. Acta Otolaryngol, 57: 288-293.
6. BOUTIMZINE N, LAGHMARI A, OUAZZANI I, IBRAHIMY W, MOHCINE Z. (1998). Le syndrome de Vogt-Koyanagi-Harada (aspects épidémiologiques, cliniques et évolutifs). À propos de 20 cas. J Fr Ophtalmol, 21 : 746-754.
7. BRUNO MG, MACPHERSON SD. (1949). Harada's disease. Am J Ophthalmol, 32: 513.
8. CHAN CC, PALESTINE AG, NUSSENBLATT RB. (1985). Anti-retinal auto-antibodies in Vogt-Koyanagi-Harada syndrome, Behcet's disease, and sympathetic ophthalmia. Ophthalmology, 92: 1025-1028.
9. CHUNG YM, WU RT, LIN WJ. (1989). Serum antibody levels to retinal S-antigen determined by ELISA in experimental and human uveitis. Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi, 22: 83-96.
10. DAVIS JL, MITTAL KK, FREIDLIN V, MELLOW SR, OPTICAN DC, PALESTINE AG, NUSSENBLATT RB. (1990). HLA associations and ancestry in Vogt-Koyanagi-Harada disease and sympathetic ophthalmia. Ophthalmology, 97: 1137-1142.
11. DE SMET MD, BITAR G, MAINIGI S, NUSSENBLATT RB. (2001). Human S-antigen determinant recognition in uveitis. Invest Ophthalmol Vis Sci, 42: 3233-3238.
12. FORSTER DJ, GREEN RL, RAO NA. (1991). Unilateral manifestation of the Vogt-Koyanagi-Harada syndrome in a 7-year-old child. Am J Ophthalmol, 111: 380-382.
13. FREEDLAND RJ, BOYDEN DG, MICHELSON JB, MANNIS M, SUGAR A, SUGAR J. (1985). Acute psychiatric decompensation with sudden loss of vision. Surv Ophthalmol, 30: 182-188.
14. FUJINO Y, LI Q, CHUNG H, HIKITA N, NUSSENBLATT RB, GERY I, CHAN CC. (1992). Immunopathology of experimental autoimmune uveoretinitis in primates. Autoimmunity, 13: 303-309.
15. FUJIOKA T, FUKUDA M, OKINAMI S. (1980). A statistic study of Vogt-Koyanagi-Harada syndrome. Acta Ophthalmol Jpn, 84: 1979-1982.
16. GLODDEK B, LASSMANN S, GLODDEK J, ARNOLD W. (1999). Role of S-100beta as potential autoantigen in an autoimmune disease of the inner ear. J Neuroimmunol, 101: 39-46.
17. HARADA E. (1926). Clinical study of non suppurative choroiditis. Acta Soc Ophthalmol Jpn, 30: 351-377.
18. HARADA T, SUGITA K, SAITO A, AWAYA S. (1987). Traitements des uvéites sévères à la cyclosporine A. Ophthalmologica, 195 : 21-25.
19. HAYASAKA S, OKABE H, TAKAHASHI J. (1982). Systemic corticosteroid treatment in Vogt-Koyanagi-Harada disease. Graefes Arch Clin Exp Ophthalmol, 218: 9-13.
20. HAYASAKA Y, HAYASAKA S. (2004). Almost simultaneous onset of Vogt-Koyanagi-Harada syndrome in co-workers, friends, and neighbors. Graefes Arch Clin Exp Ophthalmol, 242: 611-613.
21. HELVESTON WR, GILMORE R. (1996). Treatment of Vogt-Koyanagi-Harada syndrome with intravenous immunoglobulin. Neurology, 46: 584-585.
22. HIRAKI Y, KUWASAKI N, SHOJI H, KAJI M, KUBOSHIRO T. (1989). Each one case of Vogt-Koyanagi-Harada disease with vestibular and cerebellar ataxia, and multiple cranial nerve palsies. Rinsho Shinkeigaku, 29: 54-58.
23. KAMONDI A, SZEGEDI A, PAPP A, SERES A, SZIRMAI I. (2000). Vogt-Koyanagi-Harada disease presenting initially as aseptic meningoencephalitis. Eur J Neurol, 7: 719-722.
24. KOBAYASHI H, LU J, CELIS E. (2001). Identification of helper T-cell epitopes that encompass or lie proximal to cytotoxic T-cell epitopes in the gp100 melanoma tumor antigen. Cancer Res, 61: 7577-7584.
25. KONDO I, YAMAGATA K, YAMAKI K, SAKURAGI S. (1994). Analysis of the candidate antigen for Harada's disease. Nippon Ganka Gakkai Zasshi, 98: 596-603.
26. KOYANAGI Y. (1929). Dysakusis, Alopecia und Poliosis bei schwerer Uveitis nicht traumatischen Ursprungs. Klin Mbl Augenheilkd, 82: 194-211.
27. LAGHMARI M, KARIM A, IBRAHIMY W, ESSAKALI NH, MOHCINE Z. (2002). Le syndrome de Vogt-Koyanagi-Harada chez l'enfant. J Fr Ophtalmol, 25 : 636-640.
28. LUBIN JR, LOEWENSTEIN JI, FREDERICK AR. (1981). Vogt-Koyanagi-Harada syndrome with focal neurologic signs. Am J Ophthalmol, 91: 332-341.
29. MANOR RS, LIVNI E, COHEN S. (1979). Cell mediated immunity to human myelin basic protein in Vogt-Koyanagi-Harada syndrome. Invest Ophthalmol Vis Sci, 18: 204-206.
30. MONDKAR SV, BISWAS J, GANESH SK. (2000). Analysis of 87 cases with Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol, 44: 296-301.
31. MOORTHY RS, INOMATA H, RAO NA. (1995). Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol, 39: 265-292.
32. NAJMAN-VAINER J, LEVINSON RD, GRAVES MC, NGUYEN BT, ENGSTROM RE, HOLLAND GN. (2001). An association between Vogt-Koyanagi-Harada disease and Guillain-Barre syndrome. Am J Ophthalmol, 131: 615-619.
33. NAKAMURA S, NAKAZAWA M, YOSHIOKA M, NAGANO I, NAKAMURA H, ONODERA J, TAMAI M. (1996). Melanin-laden macrophages in cerebrospinal fluid in Vogt-Koyanagi-Harada syndrome. Arch Ophthalmol, 114: 1184-1188.
34. NICOLAS C, GHEDIRA I, STIEMER R, TEUFEL B, HECQUET C, FAURE JP, MIRSHAHI M. (2000). Identification of visual arrestin (S-antigen) in retinal pigmented epithelial cells. Curr Eye Res, 21: 677-683.
35. NITTA E, TAKAMORI M. (1989). Wallenberg'syndrome in a case of Vogt-Koyanagi-Harada disease. Rinsho Shinkeigaku, 29: 505-508.
36. NOROSE K, YANO A, AOSAI F, SEGAWA K. (1990). Immunologic analysis of cerebrospinal fluid lymphocytes in Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci, 31: 1210-1216.
37. OHNO S, CHAR DH, KIMURA SJ, O'CONNOR GR. (1977). Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol, 83: 735-740.
38. OHNO S, MINAKAWA R, MATSUDA H. (1988). Clinical studies of Vogt-Koyanagi-Harada's disease. Jpn J Ophthalmol, 32: 334-343.
39. OKU H, ISHIKAWA S. (1994). Vestibulo-ocular reflex abnormality in Vogt-Koyanagi-Harada syndrome. Br J Ophthalmol, 78: 912-916.
40. PATTISON EM. (1965). Uveomeningoencephalitic Syndrome (Vogt-Koyanagi-Harada). Arch Neurol, 12: 197-205.
41. PERRY HD, FONT RL. (1977). Clinical and histopathologic observations in severe Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol, 83: 242-254.
42. READ RW, HOLLAND GN, RAO NA et al. (2001a). Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: Report of an international committee on nomenclature. Am J Ophthalmol, 131: 647-652.
43. READ RW, RECHODOUNI A, BUTANI N, JOHNSTON R, LABREE LD, SMITH RE, RAO NA. (2001b). Complications and prognostic factors in Vogt-Koyanagi-Harada disease. Am J Ophthalmol, 131: 599-606.
44. RUBSAMEN PE, GASS JDM. (1991). Vogt-Koyanagi-Harada syndrome (Clinical Course, Therapy, and Long-term Visual Outcome). Arch Ophthalmol, 109: 682-687.
45. SASAMOTO Y, OHNO S, MATSUDA H. (1990). Studies on corticosteroid therapy in Vogt-Koyanagi-Harada disease. Ophthalmologica, 201: 162-167.
46. SHIRATO S, HAYASHI K, MASUDA K. (1980). Acute angle closure glaucoma as an initial sign of Harada's disease - report of two cases. Jpn J Ophthalmol, 24: 260-266.
47. SNYDER DA, TESSLER HH. (1980). Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol, 90: 69-75.
48. SUGITA S, SAGAWA K, MOCHIZUCKI M, SHICHIJO S, ITOH K. (1996). Melanocyte lysis by cytotoxic T lymphocytes recognizing the MART-1 melanoma antigen in HLA-A2 patients with Vogt-Koyanagi-Harada disease. Int Immunol, 8: 799-803.
49. SUGIURA S. (1978). Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol, 22: 9-35.
50. SUSAC JO, MURTAGH FR, EGAN RA et al. (2003). MRI findings in Susac's syndrome. Neurology, 61: 1783-1787.
51. TAKAHASHI T, OHTANI S, MIYATA K, MIYATA N, SHIRATO S, MOCHIZUKI M. (2002). A clinical evaluation of uveitis-associated secondary glaucoma. Jpn J Ophthalmol, 46: 556-562.
52. TOUITOU V, ESCANDE C, BODAGHI B et al. (2005). Prise en charge diagnostique et thérapeutique du syndrome de Vogt-Koyanagi-Harada. J Fr Ophtalmol, 28 : 9-16.
53. VOGT A. (1906). Frühzeitiges Ergrauen der Zilien und Bemerkungen über den sogenannten plötzlichen Eintritt dieser Veränderung. Klin Monatsbl Augenheilkd, 44: 228-242.
54. WACKER WB, DONOSO LA, KALSOW CM, YANKEELOV JA, ORGANISCIAK DT. (1977). Experimental allergic uveitis. Isolation, characterization, and localization of a soluble uveitopathogenic antigen from bovine retina. J Immunol, 119: 1949-1958.
55. WAKABAYASHI T, MORIMURA Y, MIYAMOTO Y, OKADA AA. (2003). Changing patterns in intraocular inflammatory disease in Japan. Ocul Immunol Inflamm, 11: 277-286.
56. WEISZ JM, HOLLAND GN, ROER LN et al. (1995). Association between Vogt-Koyanagi-Harada syndrome and HLA-DR1 and -DR4 in Hispanic patients living in southern California. Ophthalmology, 102: 1012-1015.
57. WILDNER G, DIEDRICHS-MOHRING M. (2003). Autoimmune uveitis induced by molecular mimicry of peptides from rotavirus, bovine casein and retinal S-antigen. Eur J Immunol, 33: 2577-2587.
58. YAMADA K, SENJU S, SHINOHARA T et al. (2001). Humoral immune response directed against LEDGF in patients with VKH. Immunol Lett, 78: 161-168.
59. YAMAKI K, GOCHO K, HAYAKAWA K, KONDO I, SAKURAGI S. (2000). Tyrosinase family proteins are antigens specific to Vogt-Koyanagi-Harada disease. J Immunol, 165: 7323-7329.
60. YAMAKI K, TAKIYAMA N, ITHO N et al. (2005). Experimentally induced Vogt-Koyanagi-Harada disease in two Akita dogs. Exp Eye Res, 80: 273-280.